Opus Genetics, Inc. (IRD)

Opus Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	45.09	30.32	50.5	42.63	24.53
Short-Term Investments	-	0	0.02	0.05	0.22
Cash & Short-Term Investments	45.09	30.32	50.52	42.68	24.75
Cash Growth	48.70%	-39.97%	18.35%	72.44%	50.94%
Accounts Receivable	3.17	5.77	2.33	4.85	-
Other Current Assets	1.79	0.52	1.1	1.45	1.31
Total Current Assets	50.04	36.61	53.95	48.99	26.07
Net Property, Plant & Equipment	0.2	0.25	-	0.01	0.01
Total Assets	50.24	36.86	53.95	48.99	26.08
Accounts Payable	3.29	3.15	2.15	1.07	1.58
Accrued Expenses	4.49	8.15	1.82	1.68	1.73
Short-Term Debt	-	-	-	-	0.54
Other Current Liabilities	-	-	0.07	-	-
Total Current Liabilities	7.78	11.3	4.04	2.75	3.86
Other Long-Term Liabilities	27.11	-	-	-	-
Total Long-Term Liabilities	27.11	-	-	-	-
Total Liabilities	34.9	11.3	4.04	2.75	3.86
Common Stock	0.01	0	0	0	0
Additional Paid-in Capital	203.93	145.72	131.37	117.72	111.59
Retained Earnings	-188.59	-139	-81.47	-71.48	-89.37
Total Common Shareholders' Equity	15.35	6.72	49.91	46.24	22.22
Minority Interest	-	18.84	-	-	-
Shareholders' Equity	15.35	6.72	49.91	46.24	22.22
Total Liabilities & Equity	50.24	36.86	53.95	48.99	26.08
Total Debt	0	0	0	0	0.54
Net Cash (Debt)	45.09	30.32	50.52	42.68	24.22
Net Cash Growth	48.70%	-39.97%	18.35%	76.27%	47.66%
Net Cash Per Share	0.72	1.14	2.34	2.07	1.63
Book Value	15.35	6.72	49.91	46.24	22.22
Book Value Per Share	0.25	0.25	2.31	2.24	1.50
Tangible Book Value	15.35	6.72	49.91	46.24	22.22
Tangible Book Value Per Share	0.25	0.25	2.31	2.24	1.50

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q